Achieving new highs in the Frankfurt exchange. The word is out. http://www.boerse-frankfurt.de/en/equities/migme ltd ag AU000000MIG8
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%